← Insider buys
ITCI

Intra-Cellular Therapies, Inc.

EVP and Chief Commercial Officer Mark Neumann sold $847K of Intra-Cellular Therapies, Inc.

Sold$847,380
$54.31Price
15,604Shares
−26%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Tue, Mar 28. Filed Thu, Mar 30, 1:08 PM ET, during the session. Not investment advice.